TNFAIP8 and liver cancer: We found that TNFAIP8 not only promoted liver cancer cell survival/drug resistance but also increased cell/hepatic steatosis in alcoholic fatty liver diseases (AFLD) suggesting that TNFAIP8–autophagy may contribute to early liver cancer progression by modulation of hepatic steatosis in mice and in human patients.